Opthea Limited (OPT)
NASDAQ: OPT · IEX Real-Time Price · USD
3.380
-0.050 (-1.46%)
At close: Apr 30, 2024, 12:35 PM
3.430
+0.050 (1.48%)
After-hours: Apr 30, 2024, 4:00 PM EDT
Opthea Revenue
In the fiscal year ending June 30, 2023, Opthea had annual revenue of $385.28K with 93.60% growth.
Revenue (ttm)
$385.28K
Revenue Growth
+93.60%
P/S Ratio
718.25
Revenue / Employee
$16,053
Employees
24
Market Cap
276.72M USD
Revenue Chart
* The company reports in AUD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 385.28K | 186.27K | 93.60% |
Jun 30, 2022 | 199.01K | 103.44K | 108.24% |
Jun 30, 2021 | 95.56K | -5.13K | -5.09% |
Jun 30, 2020 | 100.69K | -610.08K | -85.83% |
Jun 30, 2019 | 710.77K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sharecare | 445.25M |
Procaps Group | 414.10M |
GeneDx Holdings | 202.57M |
AxoGen | 159.01M |
Kamada | 142.52M |
Verrica Pharmaceuticals | 5.12M |
Nyxoah | 4.83M |
XOMA Corporation | 4.76M |
OPT News
- 5 days ago - Opthea to Present at the OIS Retina Innovation Summit at ARVO - GlobeNewsWire
- 21 days ago - Opthea Appoints John Han, PharmD, as VP Medical Affairs - GlobeNewsWire
- 25 days ago - Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 27 days ago - Opthea Appoints Sujal Shah to the Board of Directors - GlobeNewsWire
- 6 weeks ago - Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024 - GlobeNewsWire
- 7 weeks ago - Opthea to Participate in the Leerink Partners Global Biopharma Conference - GlobeNewsWire
- 2 months ago - Opthea Reports Half-Year Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor - GlobeNewsWire